New data from the UK Health Security Agency, published last Friday, shows a steep increase… The post Rising syphilis rates in West Midlands cause concern first appeared on beyondpositive. [...]
Earlier this month, Gilead Sciences announced that it had signed non-exclusive, royalty-free voluntary licensing agreements… The post Gilead to support generic lenacapavir in low-income nations first appeared on beyondpositive. [...]
HIV and sexual health activists protested today at Gilead Sciences’ London Office demanding the company… The post Activists demand global access to HIV prevention drug first appeared on beyondpositive. [...]
New data from the PURPOSE 2 study shows that twice-yearly lenacapavir is 89% more effective… The post Twice-yearly lenacapavir 89% more effective than Truvada first appeared on beyondpositive. [...]
HEADLINES
FOLLOW US ON OUR SOCIALS
